2m 2m 2m 2m 2m 2m 2m
HUMACYTE (HUMA)
NASDAQ
$0.57+$0.001 (+0.25%)
Price as of Sep 11, 2026 7:49 PM EDT- $157.7MMarket Cap
- -61.39%1-Year Change
- BiotechnologyIndustry
HUMACYTE (HUMA)
$0.57+$0.001 (+0.25%)
HUMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.57 | ||
Change | +$0.0005 (+0.09%) | ||
Open | $0.58 | ||
High | $0.59 | ||
Low | $0.56 | ||
Previous Close | $0.57 | ||
Volume | 2,264,995 | ||
30-Day Average Volume | 9,651,088 | ||
1-Week Change | -6.17% | ||
1-Month Change | -20.06% | ||
1-Year Change | -61.39% | ||
3-Year Change | -84.66% | ||
5-Year Change | -95.91% | ||
Fundamentals | |||
Shares Outstanding | 277.8M | ||
Total Assets | $138.1M | ||
Market Cap | $157.7M | ||
Enterprise Value | $114.1M | ||
Period: QTR TTM FY | |||
Revenue | $406,000.00 | ||
Net Income | -$36.8M | ||
Free Cash Flow | -$22.2M | ||
EBIT | -$36.7M | ||
EBITDA | -$35.4M | ||
Net Working Capital | $77.8M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 281 | ||
P/B | 5 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue